Carboxylate-derived calixarenes with high selectivity for actinium-225

被引:27
作者
Chen, XY [1 ]
Ji, M
Fisher, DR
Wai, CM
机构
[1] Univ Idaho, Dept Chem, Moscow, ID 83844 USA
[2] PNNL, Mol Biosci Dept, Richland, WA 99352 USA
关键词
D O I
10.1039/a706776c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The binding properties of two ligands, 5,11,17,23-tetra-tert-butyl-25,26,27,28-tetrakis(carboxymethoxy)calix[4]arene 1 and 5,11,17,23,29,35-hexa-tert-butyl-37,38,39,40,41,42-hexakiscarboxymethoxy)calix[6]arene 2, which show high selectivity for Ac-225(3+) (an alpha-emitter with t(1/2) = 10 days) over Na+, K+, Mg2+, Ca2+ and Zn2+ are described.
引用
收藏
页码:377 / 378
页数:2
相关论文
共 21 条
[1]  
ANDERSON CJ, 1992, J NUCL MED, V33, P2006
[2]   Complexation of Pr3+, Eu3+, Yb3+ and Th4+ ions by calixarene carboxylates [J].
ArnaudNeu, F ;
Cremin, S ;
Harris, S ;
McKervey, MA ;
SchwingWeill, MJ ;
Schwinte, P ;
Walker, A .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1997, (03) :329-334
[3]  
Baes C.F., 1976, HYDROLYSIS CATIONS
[4]   SYNTHESIS OF A KINETICALLY STABLE Y-90 LABELED MACROCYCLE ANTIBODY CONJUGATE [J].
COX, JPL ;
JANKOWSKI, KJ ;
KATAKY, R ;
PARKER, D ;
BEELEY, NRA ;
BOYCE, BA ;
EATON, MAW ;
MILLAR, K ;
MILLICAN, AT ;
HARRISON, A ;
WALKER, C .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1989, (12) :797-798
[5]   IMMUNOCHEMICAL ASPECTS OF MONOCLONAL-ANTIBODIES IMPORTANT FOR RADIOPHARMACEUTICAL DEVELOPMENT [J].
DENARDO, SJ ;
PENG, JSB ;
DENARDO, GL ;
MILLS, SL ;
EPSTEIN, AL .
NUCLEAR MEDICINE AND BIOLOGY, 1986, 13 (04) :303-&
[6]  
DESPHANDE SV, 1988, J NUCL MED, V29, P217
[7]  
GEELINGS MW, 1993, INT J BIOL MARKER, V8, P180
[8]  
GEELINGS MW, 1993, NUCL MED COMMUN, V14, P121
[9]   THE FEASIBILITY OF AC-225 AS A SOURCE OF ALPHA-PARTICLES IN RADIOIMMUNOTHERAPY [J].
GEERLINGS, MW ;
KASPERSEN, FM ;
APOSTOLIDIS, C ;
VANDERHOUT, R .
NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (02) :121-125
[10]  
KLEIN JL, 1988, ANTIBODY IMMUNOCONJ, V1, P55